AMRUTAJAN HEALTH LTD (AMRUTANJAN) financials

AMRUTAJAN HEALTH LTD (AMRUTANJAN) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink.[1]

Market Cap: ₹1,460Cr.
Current Price: ₹506
Stock P/E: 23.5
ROE: 18.4%
ROCE: 24.8%
Book Value: ₹128
Dividend Yield: 0.97%
52W High / Low: ₹760/476

In Jun 2026, AMRUTAJAN HEALTH LTD (AMRUTANJAN) reported sales ₹102.97 Cr and net profit ₹4.37 Cr.

Annual TTM: sales ₹511 Cr, net profit ₹54 Cr.

Shareholding: Promoters 46.52% (Jun 2026), FIIs 2.44% (Jun 2026), DIIs 12.29% (Jun 2026), Public 38.72% (Jun 2026), Others 0.04% (Jun 2026).

AMRUTANJAN quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	109.92	122.75	135.41	94.05	117.70	141.04	149.77	102.97
Expenses	96.32	99.40	117.71	85.61	101.18	115.87	124.22	96.73
Operating Profit	13.60	23.35	17.70	8.44	16.52	25.17	25.55	6.24
OPM %	12.37%	19.02%	13.07%	8.97%	14.04%	17.85%	17.06%	6.06%
Other Income	4.05	4.36	4.82	4.43	4.30	2.87	-2.88	1.78
Interest	0.06	0.06	0.04	0.05	0.05	0.05	0.05	0.04
Depreciation	1.65	1.66	1.62	1.53	1.56	1.62	1.61	1.92
Profit before tax	15.94	25.99	20.86	11.29	19.21	26.37	21.01	6.06
Tax %	25.97%	25.93%	27.23%	26.40%	27.33%	26.20%	22.94%	28.05%
Net Profit	11.80	19.25	15.18	8.31	13.96	19.45	16.19	4.37
EPS in Rs	4.08	6.66	5.25	2.87	4.83	6.73	5.60	1.51
Raw PDF	—	—	—	—	—	—	—	—

AMRUTANJAN profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	261	333	406	380	421	452	503	511
Expenses	231	258	326	335	369	394	427	438
Operating Profit	31	75	80	45	52	58	76	73
OPM %	12%	22%	20%	12%	12%	13%	15%	14%
Other Income	8	11	15	15	16	18	9	6
Interest	0	1	1	0	0	0	0	0
Depreciation	4	4	4	5	6	7	6	7
Profit before tax	34	82	91	54	62	69	78	73
Tax %	27%	25%	26%	26%	27%	26%	26%	—
Net Profit	25	61	67	40	45	51	58	54
EPS in Rs	8.58	20.93	22.99	13.63	15.55	17.58	20.03	18.67
Dividend Payout %	24%	20%	20%	34%	30%	26%	24%	—

AMRUTANJAN balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3	3	3	3	3	3	3	3
Reserves	143	156	213	262	288	286	324	367
Borrowings	0	2	1	1	1	2	2	2
Other Liabilities	42	44	57	84	70	77	93	137
Total Liabilities	188	205	274	350	362	367	421	509
Fixed Assets	26	26	23	28	49	50	49	51
CWIP	0	0	2	17	1	2	16	106
Investments	18	18	18	13	5	0	0	3
Other Assets	144	161	232	291	307	315	356	349
Total Assets	188	205	274	350	362	367	421	509

AMRUTANJAN cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	21	18	91	52	20	28	51	36
Cash from Investing Activity	-11	-14	-88	-36	-2	19	-31	-21
Cash from Financing Activity	-7	-12	-7	-17	-15	-48	-13	-14
Net Cash Flow	3	-7	-4	-1	3	-1	6	1
Free Cash Flow	19	16	89	29	11	21	15	-19
CFO/OP	101%	95%	146%	96%	81%	86%	118%	72%

AMRUTANJAN shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	46.52%	46.52%	46.52%	46.52%	46.52%	46.52%	46.52%	46.52%
FIIs	2.34%	2.30%	2.30%	2.41%	2.38%	2.27%	2.17%	2.44%
DIIs	10.60%	11.13%	11.41%	12.70%	12.90%	13.00%	12.66%	12.29%
Public	40.50%	40.01%	39.75%	38.34%	38.16%	38.18%	38.61%	38.72%
Others	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%
No. of Shareholders	54,536	53,856	51,674	49,431	47,954	46,675	45,805	45,135

AMRUTANJAN key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	47	37	19	34	32	42	45	44
Inventory Days	45	74	45	53	58	50	45	56
Days Payable	92	98	106	122	95	96	113	106
Cash Conversion Cycle	0	13	-41	-35	-6	-5	-23	-6
Working Capital Days	30	70	28	92	117	173	99	94
ROCE %	25%	23%	44%	38%	19%	21%	22%	25%

AMRUTANJANUpdated 13 Oct 2026, 16:36

Amrutajan Health Ltd

AMRUTANJANUpdated 13 Oct 2026, 16:36

Market Cap

₹1,460Cr.

Current Price

₹506

High / Low

₹760/476

Stock P/E

23.5

ROE18.4%

ROCE24.8%

Book Value₹128

Face Value₹1.00

Dividend Yield0.97%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	77.86	0.02	70.71	3.69	1.39	9.43	25.56	7.01	2.4
Sep 2023	99.31	0.03	92.47	3.95	1.55	9.21	25.62	6.85	2.37
Dec 2023	116.99	0.05	95.42	3.76	1.58	23.7	26.41	17.45	6.04
Mar 2024	127.06	0.05	110.82	4.95	1.53	19.61	30.34	13.66	4.72
Jun 2024	83.74	0.06	80.19	4.45	1.59	6.35	27.24	4.62	1.6
Sep 2024	109.92	0.06	96.32	4.05	1.65	15.94	25.97	11.8	4.08
Dec 2024	122.75	0.06	99.4	4.36	1.66	25.99	25.93	19.25	6.66
Mar 2025	135.41	0.04	117.71	4.82	1.62	20.86	27.23	15.18	5.25
Jun 2025	94.05	0.05	85.61	4.43	1.53	11.29	26.4	8.31	2.87
Sep 2025	117.7	0.05	101.18	4.3	1.56	19.21	27.33	13.96	4.83
Dec 2025	141.04	0.05	115.87	2.87	1.62	26.37	26.2	19.45	6.73
Mar 2026	149.77	0.05	124.22	-2.88	1.61	21.01	22.94	16.19	5.6
Jun 2026	102.97	0.04	96.73	1.78	1.92	6.06	28.05	4.37	1.51

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	154	1	130	5	2	26	35	17	5.86
Mar 2016	174	0	143	6	3	35	35	22	7.68
Mar 2017	207	0	178	7	2	34	35	22	7.47
Mar 2018	220	0	192	8	3	33	39	20	6.84
Mar 2019	253	0	222	7	3	35	29	25	8.39
Mar 2020	261	0	231	8	4	34	27	25	8.58
Mar 2021	333	1	258	11	4	82	25	61	20.93
Mar 2022	406	1	326	15	4	91	26	67	22.99
Mar 2023	380	0	335	15	5	54	26	40	13.63
Mar 2024	421	0	369	16	6	62	27	45	15.55
Mar 2025	452	0	394	18	7	69	26	51	17.58
Mar 2026	503	0	427	9	6	78	26	58	20.03
TTM	511	0	438	6	7	73	—	54	18.67

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	46.52%
FIIs	2.44%
DIIs	12.29%
Public	38.72%
Others	0.04%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public	Others
Sep 2023	50.59%	0.75%	7.1%	41.39%	0.18%
Dec 2023	50.59%	0.8%	7.24%	41.19%	0.18%
Mar 2024	50.59%	1.38%	7.29%	40.66%	0.07%
Jun 2024	50.58%	1.55%	7.32%	40.47%	0.07%
Sep 2024	46.52%	2.34%	10.6%	40.5%	0.04%
Dec 2024	46.52%	2.3%	11.13%	40.01%	0.04%
Mar 2025	46.52%	2.3%	11.41%	39.75%	0.04%
Jun 2025	46.52%	2.41%	12.7%	38.34%	0.04%
Sep 2025	46.52%	2.38%	12.9%	38.16%	0.04%
Dec 2025	46.52%	2.27%	13%	38.18%	0.04%
Mar 2026	46.52%	2.17%	12.66%	38.61%	0.04%
Jun 2026	46.52%	2.44%	12.29%	38.72%	0.04%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	3	102	0	25	130	13	4	14	100	130
Mar 2016	3	118	0	28	149	22	1	10	116	149
Mar 2017	3	113	2	34	152	27	1	10	115	152
Mar 2018	3	126	0	38	166	28	0	8	131	166
Mar 2019	3	143	0	42	188	26	0	18	144	188
Mar 2020	3	156	2	44	205	26	0	18	161	205
Mar 2021	3	213	1	57	274	23	2	18	232	274
Mar 2022	3	262	1	84	350	28	17	13	291	350
Mar 2023	3	288	1	70	362	49	1	5	307	362
Mar 2024	3	286	2	77	367	50	2	0	315	367
Mar 2025	3	324	2	93	421	49	16	0	356	421
Mar 2026	3	367	2	137	509	51	106	3	349	509

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	19	-5	-12	2
Mar 2016	21	1	-11	12
Mar 2017	8	0	-5	3
Mar 2018	19	-8	-9	2
Mar 2019	21	-11	-7	3
Mar 2020	18	-14	-12	-7
Mar 2021	91	-88	-7	-4
Mar 2022	52	-36	-17	-1
Mar 2023	20	-2	-15	3
Mar 2024	28	19	-48	-1
Mar 2025	51	-31	-13	6
Mar 2026	36	-21	-14	1

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	62	55	51	46	47	37	19	34	32	42	45	44
Inventory Days	44	44	44	40	45	74	45	53	58	50	45	56
Days Payable	46	51	110	102	92	98	106	122	95	96	113	106
Cash Conversion Cycle	61	48	-15	-16	0	13	-41	-35	-6	-5	-23	-6
Working Capital Days	42	45	76	26	30	70	28	92	117	173	99	94
ROCE %	26%	29%	28%	25%	25%	23%	44%	38%	19%	21%	22%	25%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of AMRUTAJAN HEALTH LTD (AMRUTANJAN)?

The reported market capitalisation for AMRUTAJAN HEALTH LTD (AMRUTANJAN) is ₹1,460Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of AMRUTANJAN?

The current price shown for AMRUTAJAN HEALTH LTD (AMRUTANJAN) on Fincrux is ₹506 with a 52-week high/low of ₹760/476.

What is the P/E ratio of AMRUTAJAN HEALTH LTD (AMRUTANJAN)?

The stock P/E for AMRUTAJAN HEALTH LTD (AMRUTANJAN) is 23.5 on Fincrux, with ROE at 18.4% and ROCE at 24.8%.

What were AMRUTANJAN latest quarterly results?

For Jun 2026, AMRUTAJAN HEALTH LTD (AMRUTANJAN) reported sales ₹102.97 Cr and net profit ₹4.37 Cr (figures in ₹ crore unless noted).

What are AMRUTANJAN annual sales and net profit?

For TTM, AMRUTAJAN HEALTH LTD (AMRUTANJAN) shows sales of ₹511 Cr and net profit of ₹54 Cr on the Fincrux profit & loss statement.

Who owns AMRUTAJAN HEALTH LTD (AMRUTANJAN)?

Latest shareholding for AMRUTAJAN HEALTH LTD (AMRUTANJAN) on Fincrux: Promoters 46.52% (Jun 2026), FIIs 2.44% (Jun 2026), DIIs 12.29% (Jun 2026), Public 38.72% (Jun 2026), Others 0.04% (Jun 2026).

Where can I find AMRUTAJAN HEALTH LTD (AMRUTANJAN) financials?

AMRUTAJAN HEALTH LTD (AMRUTANJAN) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show AMRUTANJAN balance sheet and cash flow?

Yes. The AMRUTAJAN HEALTH LTD (AMRUTANJAN) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 16:36